Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Fexaclear Fexofenadine hydrochloride 120mg Film coated tablet Dr Reddy’s New Zealand Limited Dr Reddy’s Laboratories Limited, Bachupally, India
|
Product: Active Ingredient:
Dosage Form: New Zealand Sponsor: Manufacturer:
|
Proveblue Methylthioninium chloride hydrate 5mg/mL equivalent to methylthioninium chloride trihydrate 5mg/mL Solution for injection Clinect NZ Pty Limited c/o Ebos Group Limited Cenexi SAS, Paris, France
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Robitussin Chesty Cough Guaifenesin 200mg Liquid filled capsule Pfizer New Zealand Limited Catalent Australia Pty Limited, Melbourne, Australia
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Synagis Palivizumab 50mg/0.5mL Solution for injection AbbVie Limited Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany MedImmune Pharma BV, Nijmegen, Netherlands
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Synagis Palivizumab 100mg/1mL Solution for injection AbbVie Limited Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany MedImmune Pharma BV, Nijmegen, Netherlands
|
Dated this 21st day of July 2016.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).